MedPath

S-288310

Generic Name
S-288310

Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer

Phase 2
Conditions
Non-small- Cell Lung Cancer
Interventions
Drug: Placebo
First Posted Date
2015-04-07
Last Posted Date
2017-12-21
Lead Sponsor
Tokyo University
Target Recruit Count
60
Registration Number
NCT02410369
Locations
🇯🇵

Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer

Phase 2
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
First Posted Date
2012-05-07
Last Posted Date
2015-08-13
Lead Sponsor
Shiga University
Target Recruit Count
45
Registration Number
NCT01592617
Locations
🇯🇵

Department of Medical Oncology, Shiga University of Medical Science Hospital, Otsu, Shiga, Japan

© Copyright 2025. All Rights Reserved by MedPath